Therapy of obesity in women with PCOS using GLP-1 analogues — benefits and limitations [Terapia otył...
Therapy of obesity in women with PCOS using GLP-1 analogues — benefits and limitations [Terapia otyłości u kobiet z PCOS przy zastosowaniu analogów GLP-1 — korzyści i ograniczenia]
About this item
Full title
Author / Creator
Publisher
Wydawnictwo Via Medica
Journal title
Language
English
Formats
Publication information
Publisher
Wydawnictwo Via Medica
Subjects
More information
Scope and Contents
Contents
Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder among women of reproductive age. The incidence ranges from approx. 6% to 20%. PCOS is characterized by a spectrum of symptoms and clinical features that includes ovarian dysfunction, clinical and/or biochemical hyperandrogenism, and ultrasound evidence of morphologically polycys...
Alternative Titles
Full title
Therapy of obesity in women with PCOS using GLP-1 analogues — benefits and limitations [Terapia otyłości u kobiet z PCOS przy zastosowaniu analogów GLP-1 — korzyści i ograniczenia]
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2709615254
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2709615254
Other Identifiers
ISSN
0423-104X
E-ISSN
2299-8306
DOI
10.5603/EP.a2022.0047
